Archives of Clinical Infectious Diseases

Published by: Kowsar

Consideration of Invasive Fungal Infections in Immunocompetent Hosts

Parisa Badiee 1 , * and Mehrzad Zare 1
Authors Information
1 Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Archives of Clinical Infectious Diseases: October 2017, 12 (4); e66111
  • Published Online: September 19, 2017
  • Article Type: Editorial
  • Received: December 3, 2016
  • Revised: April 10, 2017
  • Accepted: April 15, 2017
  • DOI: 10.5812/archcid.66111

To Cite: Badiee P, Zare M. Consideration of Invasive Fungal Infections in Immunocompetent Hosts, Arch Clin Infect Dis. 2017 ; 12(4):e66111. doi: 10.5812/archcid.66111.

Copyright © 2017, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
Acknowledgements
References
  • 1. Jiang S. Immunity against Fungal Infections. Immunol Immunogenet Insights. 2016;8. doi: 10.4137/iii.s38707.
  • 2. Jimenez-Lopez C, Lorenz MC. Fungal immune evasion in a model host-pathogen interaction: Candida albicans versus macrophages. PLoS Pathog. 2013;9(11). e1003741. doi: 10.1371/journal.ppat.1003741. [PubMed: 24278014].
  • 3. Badiee P, Alborzi A, Malekhosseini SA, Nikeghbalian S, Shakiba E. Determining the incidence of aspergillosis after liver transplant. Exp Clin Transplant. 2010;8(3):220-3. [PubMed: 20716040].
  • 4. Badiee P, Kordbacheh P, Alborzi A, Ramzi M, Shakiba E. Molecular detection of invasive aspergillosis in hematologic malignancies. Infection. 2008;36(6):580-4. doi: 10.1007/s15010-008-7385-8. [PubMed: 18854937].
  • 5. Cetinkaya E, Cortuk M, Gul S, Mert A, Boyaci H, Cam E, et al. Simultaneous Chronic Invasive Fungal Infection and Tracheal Fungus Ball Mimicking Cancer in an Immunocompetent Patient. Case Rep Med. 2016;2016:2416452. doi: 10.1155/2016/2416452. [PubMed: 27418930].
  • 6. Mohammadi H, Sadeghi S, Zandi S. Central Nervous System Aspergilloma in an Immunocompetent Patient: A Case Report. Iran J Public Health. 2015;44(6):869-72. [PubMed: 26258101].
  • 7. Dowling JK, Mansell A. Toll-like receptors: the swiss army knife of immunity and vaccine development. Clin Transl Immunology. 2016;5(5). e85. doi: 10.1038/cti.2016.22. [PubMed: 27350884].
  • 8. Kruger T, Luo T, Schmidt H, Shopova I, Kniemeyer O. Challenges and Strategies for Proteome Analysis of the Interaction of Human Pathogenic Fungi with Host Immune Cells. Proteomes. 2015;3(4):467-95. doi: 10.3390/proteomes3040467. [PubMed: 28248281].
  • 9. Konstantinovas C, de Oliveira Mendes TA, Vannier-Santos MA, Lima-Santos J. Modulation of Human Immune Response by Fungal Biocontrol Agents. Front Microbiol. 2017;8:39. doi: 10.3389/fmicb.2017.00039. [PubMed: 28217107].
  • 10. Chai LY, Netea MG, Vonk AG, Kullberg BJ. Fungal strategies for overcoming host innate immune response. Med Mycol. 2009;47(3):227-36. doi: 10.1080/13693780802209082. [PubMed: 18654922].
  • 11. Lehrnbecher T, Becker K, Groll AH. Current algorithms in fungal diagnosis in the immunocompromised host. Human fungal pathogen identification: Methods and protocols. 2017. p. 67-84.
  • 12. Parisa B, Alborzi A, Shakiba E, Ziyaeyan M, Rasuli M. Molecular Identification and In-Vitro Susceptibility of Candida albicans and C. dubliniensis Isolated from Immu-nocompromised Patients. Iran Red Crescent Med J. 2009;11(4):391-7.
  • 13. Badiee P, Alborzi A, Moeini M, Haddadi P, Farshad S, Japoni A, et al. Antifungal susceptibility of the aspergillus species by Etest and CLSI reference methods. Arch Iran Med. 2012;15(7):429-32. [PubMed: 22724880].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments